Olumiant ® ▼ (baricitinib)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Olumiant Summary of Product Characteristics (SmPC)

Olumiant® ▼ (baricitinib): Gluten

Olumiant tablets do not contain Gluten.

Further information

The active ingredient of Olumiant is Baricitinib.1

Olumiant tablets contain Mannitol that is developed from maize or wheat starch.

Olumiant tablets do not contain ingredients that come from barley, oat, rye or spelt.1

The tablet cores contain2

  • cellulose, microcrystalline

  • croscarmellose sodium

  • magnesium stearate

  • mannitol

The film coating contains2

  • iron oxide red (E172)

  • lecithin (soya) (E322)

  • macrogol

  • poly (vinyl alcohol)

  • talc

  • titanium dioxide (E171)

This medicinal product contains less than 1 mmol sodium (23 mg) per tablet, i.e., essentially “sodium- free”.2

Olumiant is contraindicated in case of hypersensitivity to the active substance or to any of the excipients.2


1. Data on file, Eli Lilly and Company and/or one of its subsidiaries.

2. Olumiant [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Date of Last Review: November 02, 2020

Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request